AcuCort strives to create added value for shareholders and the company’s stakeholder groups. We create value by identifying, developing and commercializing smart medicines that meet the patient’s needs for a user-friendly and effective treatment.
The development candidates are based on existing and well-documented substances in indication areas where there is a great medical need and commercial interest in new and innovative drugs that bring benefits, such as simple administration. The approved drug is commercialized in partnership with a global network of licensees and/or distributors. Our vision is to develop and commercialize new innovative drugs that offer both clinical relevance and patient benefits.
We are committed to conserving the company’s resources. We encourage effective cooperation and safeguard our agile organization, which is composed of employees and external expertise in areas where AcuCort lacks resources or only temporarily needs them. Together, the team has a solid experience and expertise in pharmaceutical and business development. Our employees are important for the company’s success and we strive to attract and retain highly competent and committed team players who actively contribute to the development of the company.
We comply with laws, regulations, codes and guidelines and standards for good practices related to safety, quality, environment, drug development, work environment and business ethics. Our ambition is to develop new drugs that are ethically motivated and that make a difference for the patients who need them. We believe that these are the basic prerequisites for AcuCort’s long-term and sustainable growth.